InnoCare Announces First Psoriasis Patient Dosed in Clinical Trial of TYK2 Allosteric Inhibitor ICP-488 in China
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment…
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment…
Powered by data virtualization, the award winning Denodo Platform is now available on the Alibaba…
License covers Nokia's (www.Nokia.com) fundamental inventions in 5G and other technologies; Nokia to receive payments…
SHENZHEN, China--(BUSINESS WIRE)--SMOORE has gone from strength to strength with its pioneering Power Alpha solution…
SINGAPORE - Media OutReach - 4 July 2023 - At the recently concluded Olympic Esports…
Latest data from the phase III OLYMPIA 2 trial presented at the World Congress of…
Data demonstrate superiority vs. placebo in preventing generalized pustular psoriasis (GPP) flares up to 48…
SANYA, CHINA - Media OutReach - 4 July 2023 - VERTU, the world's premier luxury…
JOHANNESBURG, GAUTENG, ZA - Media OutReach - 4 July 2023 - The highly anticipated Digital…
BANGKOK, THAILAND - Media OutReach - 4 July 2023 - The <BTS EXHIBITION : Proof>…